Pharmacokinetic Herb-Drug Interactions: Insight into Mechanisms and Consequences

European Journal of Drug Metabolism and Pharmacokinetics

Volume 41, Issue 2, 1 April 2016, Pages 93-108

Oga, E.F.^a , 

Sekine, S.^b, 

Shitara, Y.^c, 

Horie, T.^d

 

^a  School of Pharmacy and Biomedical Sciences, University of Central Lancashire, Preston, Lancashire, United Kingdom
^b  Department of Biopharmaceutics, Chiba University, Chiba, Japan
^c  Pharmacokinetics Laboratory, Meiji Seika Pharma Co., Ltd, Yokohama, Japan

View additional affiliations

View references (148)

Abstract

Herbal medicines are currently in high demand, and their popularity is steadily increasing. Because of their perceived effectiveness, fewer side effects and relatively low cost, they are being used for the management of numerous medical conditions. However, they are capable of affecting the pharmacokinetics and pharmacodynamics of coadministered conventional drugs. These interactions are particularly of clinically relevance when metabolizing enzymes and xenobiotic transporters, which are responsible for the fate of many drugs, are induced or inhibited, sometimes resulting in unexpected outcomes. This article discusses the general use of herbal medicines in the management of several ailments, their concurrent use with conventional therapy, mechanisms underlying herb-drug interactions (HDIs) as well as the drawbacks of herbal remedy use. The authors also suggest means of surveillance and safety monitoring of herbal medicines. Contrary to popular belief that "herbal medicines are totally safe," we are of the view that they are capable of causing significant toxic effects and altered pharmaceutical outcomes when coadministered with conventional medicines. Due to the paucity of information as well as sometimes conflicting reports on HDIs, much more research in this field is needed. The authors further suggest the need to standardize and better regulate herbal medicines in order to ensure their safety and efficacy when used alone or in combination with conventional drugs. © 2015 Springer International Publishing Switzerland.

ISSN: 03787966 CODEN: EJDPDSource Type: Journal Original language: English

DOI: 10.1007/s13318-015-0296-zDocument Type: Review

Publisher: Springer-Verlag France

References (148)

View in search results format

• All
• • Export |
  • Print |
  • E-mail |
  • Create bibliography

• 
  1

  Sasidharan, S., Chen, Y., Saravanan, D., Sundram, K.M., Yoga Latha, L.
  

  Extraction, isolation and characterization of bioactive compounds from plants' extracts
  (2011) African Journal of Traditional, Complementary and Alternative Medicines, 8 (1), pp. 1-10. Cited 69 times.
  http://www.bioline.org.br/pdf?tc11001
  

  • View at Publisher
• 
  2

  Calixto, J.B.
  

  Efficacy, safety, quality control, marketing and regulatory guidelines for herbal medicines (phytotherapeutic agents)
  (2000) Brazilian Journal of Medical and Biological Research, 33 (2), pp. 179-189. Cited 346 times.
  

  • View at Publisher
• 
  3

  Mahady, G.B.
  

  Global harmonization of herbal health claims
  (2001) Journal of Nutrition, 131 (3 SUPPL.), pp. 1120S-1123S. Cited 81 times.
  

  • View at Publisher
• 
  4

  World Health Organization
  (2008) Traditional Medicine
  

  •  
• 
  5

  Tuffs, A.
  

  Three out of four Germans have used complementary or natural remedies.
  (2002) BMJ (Clinical research ed.), 325 (7371), p. 990. Cited 14 times.
  

  • View at Publisher
• 
  6

  Tachjian, A., Maria, V., Jahangir, A.
  

  Use of Herbal Products and Potential Interactions in Patients With Cardiovascular Diseases
  (2010) Journal of the American College of Cardiology, 55 (6), pp. 515-525. Cited 133 times.
  doi: 10.1016/j.jacc.2009.07.074
  

  • View at Publisher
• 
  7

  Komiya, A., Watanabe, A., Fuse, H.
  

  Herbal medicine in Japan
  (2011) Journal of Men's Health, 8 (SUPPL. 1), pp. S15-S18. Cited 3 times.
  doi: 10.1016/S1875-6867(11)60012-2
  

  • View at Publisher
• 
  8

  Moschik, E.C., Mercado, C., Yoshino, T., Matsuura, K., Watanabe, K.
  

  Usage and attitudes of physicians in Japan concerning traditional Japanese medicine (Kampo Medicine): A descriptive evaluation of a representative questionnaire-based survey
  (2012) Evidence-based Complementary and Alternative Medicine, 2012, art. no. 139818. Cited 11 times.
  doi: 10.1155/2012/139818
  

  • View at Publisher
• 
  9

  Zhang, X.
  Regulatory situation of herbal medicines: A worldwide review
  (1998) WHO Traditional Medicine Programme, p. 45.
  

  •  
• 
  10

  Walker, D.R.
  (2015) Report on the Regulation of Herbal Medicines and Practitioners. Cited 2 times.
  

  •  
• 
  11

  Boyle, S.P., Doolan, P.J., Andrews, C.E., Reid, R.G.
  

  Evaluation of quality control strategies in Scutellaria herbal medicines
  (2011) Journal of Pharmaceutical and Biomedical Analysis, 54 (5), pp. 951-957. Cited 23 times.
  doi: 10.1016/j.jpba.2010.11.019
  

  • View at Publisher
• 
  12

  Newman, D.J., Cragg, G.M.
  

  Natural products as sources of new drugs over the 30 years from 1981 to 2010
  (2012) Journal of Natural Products, 75 (3), pp. 311-335. Cited 1450 times.
  doi: 10.1021/np200906s
  

  • View at Publisher
• 
  13

  Lahlou, M.
  The success of natural products in drug discovery
  (2013) Pharmacol Pharm, 4, pp. 17-31. Cited 32 times.
  

  •  
• 
  14

  Katiyar, C.
  Drug discovery from plant sources: An integrated approach
  (2012) Ayu, 33 (1), pp. 10-19.
  23049178 3456845
  

  •  
• 
  15

  Giacomini, K.M., Huang, S.-M., Tweedie, D.J., Benet, L.Z., Brouwer, K.L.R., Chu, X., Dahlin, A., (...), Zhang, L.
  

  Membrane transporters in drug development
  (2010) Nature Reviews Drug Discovery, 9 (3), pp. 215-236. Cited 1164 times.
  doi: 10.1038/nrd3028
  

  • View at Publisher
• 
  16

  Müller, A.C., Kanfer, I.
  

  Potential pharmacokinetic interactions between antiretrovirals and medicinal plants used as complementary and African traditional medicines
  (2011) Biopharmaceutics and Drug Disposition, 32 (8), pp. 458-470. Cited 21 times.
  doi: 10.1002/bdd.775
  

  • View at Publisher
• 
  17

  Guengerich, F.P.
  

  Cytochrome P450s and other enzymes in drug metabolism and toxicity
  (2006) AAPS Journal, 8 (1), art. no. 12, pp. E105-E111. Cited 300 times.
  http://www.aapsj.org/view.asp?art=aapsj080112
  doi: 10.1208/aapsj080112
  

  • View at Publisher
• 
  18

  Paine, M.F., Hart, H.L., Ludington, S.S., Haining, R.L., Rettie, A.E., Zeldin, D.C.
  

  The human intestinal cytochrome P450 "pie"
  (2006) Drug Metabolism and Disposition, 34 (5), pp. 880-886. Cited 387 times.
  http://dmd.aspetjournals.org/cgi/reprint/34/5/880
  doi: 10.1124/dmd.105.008672
  

  • View at Publisher
• 
  19

  Kim, E., Sy-Cordero, A., Graf, T.N., Brantley, S.J., Paine, M.F., Oberlies, N.H.
  

  Isolation and identification of intestinal CYP3A inhibitors from ranberry (Vaccinium macrocarpon) using human intestinal microsomes
  (2011) Planta Medica, 77 (3), pp. 265-270. Cited 21 times.
  doi: 10.1055/s-0030-1250259
  

  • View at Publisher
• 
  20

  Jepson, R.G., Williams, G., Craig, J.C.
  Cranberries for preventing urinary tract infections
  (2012) Cochrane Database Syst Rev. Cited 64 times.
  10:CD001321
  

  •  
• 
  21

  Uesawa, Y., Mohri, K.
  

  Effects of cranberry juice on nifedipine pharmacokinetics in rats
  (2006) Journal of Pharmacy and Pharmacology, 58 (8), pp. 1067-1072. Cited 30 times.
  doi: 10.1211/jpp.58.8.0007
  

  • View at Publisher
• 
  22

  Lilja, J.J., Backman, J.T., Neuvonen, P.J.
  

  Effects of daily ingestion of cranberry juice on the pharmacokinetics of warfarin, tizanidine, and midazolam - Probes of CYP2C9, CYP1A2, and CYP3A4
  (2007) Clinical Pharmacology and Therapeutics, 81 (6), pp. 833-839. Cited 55 times.
  doi: 10.1038/sj.clpt.6100149
  

  • View at Publisher
• 
  23

  Ngo, C., Yan, Z., Graf, T.N., Carrizosa, D.R., Kashuba, A.D.M., Dees, E.C., Oberlies, N.H., (...), Paine, M.F.
  

  Identification of a cranberry juice product that inhibits enteric CYP3A-mediated first-pass metabolism in humans
  (2009) Drug Metabolism and Disposition, 37 (3), pp. 514-522. Cited 23 times.
  http://dmd.aspetjournals.org/cgi/reprint/37/3/514
  doi: 10.1124/dmd.108.024968
  

  • View at Publisher
• 
  24

  Penzak, S.R., Robertson, S.M., Hunt, J.D., Chairez, C., Malati, C.Y., Alfaro, R.M., Stevenson, J.M., (...), Kovacs, J.A.
  

  Echinacea purpurea significantly induces cytochrome P450 3A activity but does not alter Lopinavir-Ritonavir exposure in healthy subjects
  (2010) Pharmacotherapy, 30 (8), pp. 797-805. Cited 30 times.
  http://www.atypon-link.com/PPI/doi/pdf/10.1592/phco.30.8.797
  doi: 10.1592/phco.30.8.797
  

  • View at Publisher
• 
  25

  Gorski, J.C., Huang, S.-M., Pinto, A., Hamman, M.A., Hilligoss, J.K., Zaheer, N.A., Desai, M., (...), Hall, S.D.
  

  The effect of echinacea (Echinacea purpurea root) on cytochrome P450 activity in vivo
  (2004) Clinical Pharmacology and Therapeutics, 75 (1), pp. 89-100. Cited 170 times.
  doi: 10.1016/j.clpt.2003.09.013
  

  • View at Publisher
• 
  26

  Hansen, T.S., Nilsen, O.G.
  

  In vitro CYP3A4 metabolism: Inhibition by Echinacea purpurea and choice of substrate for the evaluation of herbal inhibition
  (2008) Basic and Clinical Pharmacology and Toxicology, 103 (5), pp. 445-449. Cited 16 times.
  doi: 10.1111/j.1742-7843.2008.00307.x
  

  • View at Publisher
• 
  27

  Eichhorn, T., Efferth, T.
  

  P-glycoprotein and its inhibition in tumors by phytochemicals derived from Chinese herbs
  (2012) Journal of Ethnopharmacology, 141 (2), pp. 557-570. Cited 41 times.
  doi: 10.1016/j.jep.2011.08.053
  

  • View at Publisher
• 
  28

  Oga, E.F., Sekine, S., Shitara, Y., Horie, T.
  

  P-glycoprotein mediated efflux in Caco-2 cell monolayers: The influence of herbals on digoxin transport
  (2012) Journal of Ethnopharmacology, 144 (3), pp. 612-617. Cited 14 times.
  doi: 10.1016/j.jep.2012.10.001
  

  • View at Publisher
• 
  29

  Li, Y., Lu, J., Paxton, J.W.
  

  The role of ABC and SLC transporters in the pharmacokinetics of dietary and herbal phytochemicals and their interactions with xenobiotics
  (2012) Current Drug Metabolism, 13 (5), pp. 624-639. Cited 14 times.
  

  • View at Publisher
• 
  30

  Hermann, R., Von Richter, O.
  

  Clinical evidence of herbal drugs as perpetrators of pharmacokinetic drug interactions
  (2012) Planta Medica, 78 (13), pp. 1458-1477. Cited 52 times.
  doi: 10.1055/s-0032-1315117
  

  • View at Publisher
• 
  31

  Dahan, A., Altman, H.
  

  Food-drug interaction: Grapefruit juice augments drug bioavailability - Mechnism, extent and relevance
  (2004) European Journal of Clinical Nutrition, 58 (1), pp. 1-9. Cited 139 times.
  doi: 10.1038/sj.ejcn.1601736
  

  • View at Publisher
• 
  32

  Bailey, D.G., Malcolm, J., Arnold, O., Spence, J.D.
  

  Grapefruit juice-drug interactions
  (1998) British Journal of Clinical Pharmacology, 46 (2), pp. 101-110. Cited 526 times.
  http://www.bjcp-journal.com/
  doi: 10.1046/j.1365-2125.1998.00764.x
  

  • View at Publisher
• 
  33

  Bailey, D.G.
  

  Fruit juice inhibition of uptake transport: A new type of food-drug interaction
  (2010) British Journal of Clinical Pharmacology, 70 (5), pp. 645-655. Cited 98 times.
  http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2125.2010.03722.x/pdf
  doi: 10.1111/j.1365-2125.2010.03722.x
  

  • View at Publisher
• 
  34

  Dresser, G.K., Bailey, D.G.
  

  The effects of fruit juices on drug disposition: A new model for drug interactions
  (2003) European Journal of Clinical Investigation, Supplement, 33 (2), pp. 10-16. Cited 101 times.
  

  • View at Publisher
• 
  35

  Fan, L., Zhang, W., Guo, D., Tan, Z.-R., Xu, P., Li, Q., Liu, Y.-Z., (...), Zhou, H.-H.
  

  The effect of herbal medicine baicalin on pharmacokinetics of rosuvastatin, substrate of organic anion-transporting polypeptide 1B1
  (2008) Clinical Pharmacology and Therapeutics, 83 (3), pp. 471-476. Cited 41 times.
  doi: 10.1038/sj.clpt.6100318
  

  • View at Publisher
• 
  36

  Zhao, D., Gao, Z.-D., Han, D.-E., Li, N., Zhang, Y.-J., Lu, Y., Li, T.-T., (...), Chen, X.-J.
  

  Influence of rifampicin on the pharmacokinetics of salvianolic acid b may involve inhibition of organic anion transporting polypeptide (Oatp) mediated influx
  (2012) Phytotherapy Research, 26 (1), pp. 118-121. Cited 9 times.
  doi: 10.1002/ptr.3522
  

  • View at Publisher
• 
  37

  Lin, C.-C., Fan, H.-Y., Kuo, C.-W., Pao, L.-H.
  

  Evaluation of chinese-herbal-medicine-induced herb-drug interactions: Focusing on organic anion transporter 1
  (2012) Evidence-based Complementary and Alternative Medicine, 2012, art. no. 967182. Cited 6 times.
  doi: 10.1155/2012/967182
  

  • View at Publisher
• 
  38

  Haschke, M.
  

  Functional interactions between P-glycoprotein and CYP3A in drug metabolism
  (2005) Expert Opinion on Drug Metabolism and Toxicology, 1 (4), pp. 641-654. Cited 63 times.
  doi: 10.1517/17425255.1.4.641
  

  • View at Publisher
• 
  39

  Hellum, B.H., Tosse, A., Hoybakk, K., Thomsen, M., Rohloff, J., Georg Nilsen, O.
  

  Potent in vitro Inhibition of CYP3A4 and P-Glycoprotein by Rhodiola rosea
  (2010) Planta Medica, 76 (4), pp. 331-338. Cited 12 times.
  doi: 10.1055/s-0029-1186153
  

  • View at Publisher
• 
  40

  Rahimi, R., Abdollahi, M.
  

  An update on the ability of St. John's wort to affect the metabolism of other drugs
  (2012) Expert Opinion on Drug Metabolism and Toxicology, 8 (6), pp. 691-708. Cited 41 times.
  doi: 10.1517/17425255.2012.680886
  

  • View at Publisher
• 
  41

  Yu, C.-P., Wu, P.-P., Hou, Y.-C., Lin, S.-P., Tsai, S.-Y., Chen, C.-T., Chao, P.-D.L.
  

  Quercetin and rutin reduced the bioavailability of cyclosporine from Neoral, an immunosuppressant, through activating P-glycoprotein and CYP 3A4
  (2011) Journal of Agricultural and Food Chemistry, 59 (9), pp. 4644-4648. Cited 36 times.
  doi: 10.1021/jf104786t
  

  • View at Publisher
• 
  42

  Markowitz, J.S., Donovan, J.L., DeVane, C.L., Taylor, R.M., Ruan, Y., Wang, J.-S., Chavin, K.D.
  

  Effect of St John's Wort on Drug Metabolism by Induction of Cytochrome P450 3A4 Enzyme
  (2003) Journal of the American Medical Association, 290 (11), pp. 1500-1504. Cited 249 times.
  doi: 10.1001/jama.290.11.1500
  

  • View at Publisher
• 
  43

  Willson, T.M., Kliewer, S.A.
  

  PXR, car and drug metabolism
  (2002) Nature Reviews Drug Discovery, 1 (4), pp. 259-266. Cited 271 times.
  

  • View at Publisher
• 
  44

  Lehmann, J.M., McKee, D.D., Watson, M.A., Willson, T.M., Moore, J.T., Kliewer, S.A.
  

  The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions
  (1998) Journal of Clinical Investigation, 102 (5), pp. 1016-1023. Cited 1103 times.
  

  • View at Publisher
• 
  45

  Kliewer, S.A., Goodwin, B., Willson, T.M.
  

  The nuclear pregnane X receptor: A key regulator of xenobiotic metabolism
  (2002) Endocrine Reviews, 23 (5), pp. 687-702. Cited 474 times.
  doi: 10.1210/er.2001-0038
  

  • View at Publisher
• 
  46

  Moore, L.B., Goodwin, B., Jones, S.A., Wisely, G.B., Serabjit-Singh, C.J., Willson, T.M., Collins, J.L., (...), Kliewer, S.A.
  

  St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor
  (2000) Proceedings of the National Academy of Sciences of the United States of America, 97 (13), pp. 7500-7502. Cited 699 times.
  doi: 10.1073/pnas.130155097
  

  • View at Publisher
• 
  47

  Geick, A., Eichelbaum, M., Burk, O.
  

  Nuclear Receptor Response Elements Mediate Induction of Intestinal MDR1 by Rifampin
  (2001) Journal of Biological Chemistry, 276 (18), pp. 14581-14587. Cited 616 times.
  doi: 10.1074/jbc.M010173200
  

  • View at Publisher
• 
  48

  Tien, E.S., Negishi, M.
  

  Nuclear receptors CAR and PXR in the regulation of hepatic metabolism
  (2006) Xenobiotica, 36 (10-11), pp. 1152-1163. Cited 55 times.
  doi: 10.1080/00498250600861827
  

  • View at Publisher
• 
  49

  Meijerman, I., Beijnen, J.H., Schellens, J.H.M.
  

  Herb-drug interactions in oncology: Focus on mechanisms of induction
  (2006) Oncologist, 11 (7), pp. 742-752. Cited 113 times.
  http://theoncologist.alphamedpress.org/cgi/reprint/11/7/742
  doi: 10.1634/theoncologist.11-7-742
  

  • View at Publisher
• 
  50

  Gratus, C., Wilson, S., Greenfield, S.M., Damery, S.L., Warmington, S.A., Grieve, R., Steven, N.M., (...), Routledge, P.
  

  The use of herbal medicines by people with cancer: A qualitative study
  (2009) BMC Complementary and Alternative Medicine, 9, art. no. 14. Cited 30 times.
  doi: 10.1186/1472-6882-9-14
  

  • View at Publisher
• 
  51

  He, S.-M., Yang, A.-K., Li, X.-T., Du, Y.-M., Zhou, S.-F.
  

  Effects of herbal products on the metabolism and transport of anticancer agents
  (2010) Expert Opinion on Drug Metabolism and Toxicology, 6 (10), pp. 1195-1213. Cited 35 times.
  doi: 10.1517/17425255.2010.510132
  

  • View at Publisher
• 
  52

  Fong, H.H.S.
  

  Integration of herbal medicine into modern medical practices: Issues and prospects
  (2002) Integrative Cancer Therapies, 1 (3), pp. 287-293. Cited 70 times.
  

  • View at Publisher
• 
  53

  Smith, P.
  

  The influence of St. John's wort on the pharmacokinetics and protein binding of imatinib mesylate
  (2004) Pharmacotherapy, 24 (11), pp. 1508-1514. Cited 87 times.
  doi: 10.1592/phco.24.16.1508.50958
  

  • View at Publisher
• 
  54

  Frye, R.F., Fitzgerald, S.M., Lagattuta, T.F., Hruska, M.W., Egorin, M.J.
  

  Effect of St John's wort on imatinib mesylate pharmacokinetics
  (2004) Clinical Pharmacology and Therapeutics, 76 (4), pp. 323-329. Cited 155 times.
  doi: 10.1016/j.clpt.2004.06.007
  

  • View at Publisher
• 
  55

  Hu, Z.-P., Yang, X.-X., Chan, S.Y., Xu, A.-L., Duan, W., Zhu, Y.-Z., Sheu, F.-S., (...), Zhou, S.-F.
  

  St. John's wort attenuates irinotecan-induced diarrhea via down-regulation of intestinal pro-inflammatory cytokines and inhibition of intestinal epithelial apoptosis
  (2006) Toxicology and Applied Pharmacology, 216 (2), pp. 225-237. Cited 30 times.
  doi: 10.1016/j.taap.2006.05.020
  

  • View at Publisher
• 
  56

  Mathijssen, R.H.J., Verweij, J., De Bruijn, P., Loos, W.J., Sparreboom, A.
  

  Effects of St. John's Wort on irinotecan metabolism
  (2002) Journal of the National Cancer Institute, 94 (16), pp. 1247-1249. Cited 288 times.
  

  • View at Publisher
• 
  57

  Reif, S., Nicolson, M.C., Bisset, D., Reid, M., Kloft, C., Jaehde, U., McLeod, H.L.
  

  Effect of grapefruit juice intake on etoposide bioavailability
  (2002) European Journal of Clinical Pharmacology, 58 (7), pp. 491-494. Cited 51 times.
  doi: 10.1007/s00228-002-0495-9
  

  • View at Publisher
• 
  58

  Hasegawa, H., Sung, J.-H., Matsumiya, S., Uchiyama, M., Inouye, Y., Kasai, R., Yamasaki, K.
  

  Reversal of daunomycin and vinblastine resistance in multidrug-resistant P388 leukemia in vitro through enhanced cytotoxicity by triterpenoids
  (1995) Planta Medica, 61 (5), pp. 409-413. Cited 59 times.
  doi: 10.1055/s-2006-958126
  

  • View at Publisher
• 
  59

  Kim, S.-W., Kwon, H.-Y., Chi, D.-W., Shim, J.-H., Park, J.-D., Lee, Y.-H., Pyo, S., (...), Rhee, D.-K.
  

  Reversal of P-glycoprotein-mediated multidrug resistance by ginsenoside Rg₃
  (2003) Biochemical Pharmacology, 65 (1), pp. 75-82. Cited 108 times.
  doi: 10.1016/S0006-2952(02)01446-6
  

  • View at Publisher
• 
  60

  Zhou, S., Lim, L.Y., Chowbay, B.
  

  Herbal Modulation of P-Glycoprotein
  (2004) Drug Metabolism Reviews, 36 (1), pp. 57-104. Cited 265 times.
  doi: 10.1081/DMR-120028427
  

  • View at Publisher
• 
  61

  Deepak, H.B., Chandrasekaran, C.V., Dethe, S., Mundkinajeddu, D., Pandre, M.K., Balachandran, J., Agarwal, A.
  

  Hepatoprotective and antioxidant activity of standardized herbal extracts
  (2012) Pharmacognosy Magazine, 8 (30), pp. 116-123. Cited 19 times.
  doi: 10.4103/0973-1296.96553
  

  • View at Publisher
• 
  62

  Olaku, O., White, J.D.
  

  Herbal therapy use by cancer patients: A literature review on case reports
  (2011) European Journal of Cancer, 47 (4), pp. 508-514. Cited 57 times.
  doi: 10.1016/j.ejca.2010.11.018
  

  • View at Publisher
• 
  63

  Lee, S.-A., Hong, S.-K., Suh, C.-I., Oh, M.-H., Park, J.-H., Choi, B.-W., Park, S.-W., (...), Paik, S.-Y.
  

  Anti-HIV-1 efficacy of extracts from medicinal plants
  (2010) Journal of Microbiology, 48 (2), pp. 249-252. Cited 7 times.
  doi: 10.1007/s12275-009-0176-9
  

  • View at Publisher
• 
  64

  Liu, J.
  

  The use of herbal medicines in early drug development for the treatment of HIV infections and AIDS
  (2007) Expert Opinion on Investigational Drugs, 16 (9), pp. 1355-1364. Cited 21 times.
  doi: 10.1517/13543784.16.9.1355
  

  • View at Publisher
• 
  65

  Bepe, N., Madanhi, N., Mudzviti, T., Gavi, S., Maponga, C.C., Morse, G.D.
  

  The impact of herbal remedies on adverse effects and quality of life in HIV-infected individuals on antiretroviral therapy
  (2011) Journal of Infection in Developing Countries, 5 (1), pp. 48-53. Cited 12 times.
  http://www.jidc.org/index.php/journal/article/download/1415/494
  
• 
  66

  Müller, A.C., Patnala, S., Kis, O., Bendayan, R., Kanfer, I.
  

  Interactions between phytochemical components of Sutherlandia frutescens and the antiretroviral, atazanavir in vitro: Implications for absorption and metabolism
  (2012) Journal of Pharmacy and Pharmaceutical Sciences, 15 (2), pp. 221-233. Cited 10 times.
  http://ejournals.library.ualberta.ca/index.php/JPPS/article/view/11652/13532
  

  • View at Publisher
• 
  67

  Patel, J., Buddha, B., Dey, S., Pal, D., Mitra, A.K.
  

  In vitro interaction of the HIV protease inhibitor ritonavir with herbal constituents: changes in P-gp and CYP3A4 activity.
  (2004) American journal of therapeutics, 11 (4), pp. 262-277. Cited 106 times.
  

  • View at Publisher
• 
  68

  Piscitelli, S.C., Burstein, A.H., Chaitt, D., Alfaro, R.M., Falloon, J.
  

  Indinavir concentrations and St John's wort
  (2000) Lancet, 355 (9203), pp. 547-548. Cited 727 times.
  

  • View at Publisher
• 
  69

  Foster, B.C., Foster, M.S., Vandenhoek, S., Krantis, A., Budzinski, J.W., Arnason, J.T., Gallicano, K.D., (...), Choudri, S.
  

  An in vitro evaluation of human cytochrome P450 3A4 and P-glycoprotein inhibition by garlic
  (2001) Journal of Pharmacy and Pharmaceutical Sciences, 4 (2), pp. 176-184. Cited 147 times.
  http://www.ualberta.ca/~csps/JPPS4(2)/B.Foster/Garlic.htm
  

  • View at Publisher
• 
  70

  Hajda, J., Rentsch, K.M., Gubler, C., Steinert, H., Stieger, B., Fattinger, K.
  

  Garlic extract induces intestinal P-glycoprotein, but exhibits no effect on intestinal and hepatic CYP3A4 in humans
  (2010) European Journal of Pharmaceutical Sciences, 41 (5), pp. 729-735. Cited 26 times.
  doi: 10.1016/j.ejps.2010.09.016
  

  • View at Publisher
• 
  71

  Piscitelli, S.C., Burstein, A.H., Welden, N., Gallicano, K.D., Falloon, J.
  

  The effect of garlic supplements on the pharmacokinetics of saquinavir
  (2002) Clinical Infectious Diseases, 34 (2), pp. 234-238. Cited 264 times.
  doi: 10.1086/324351
  

  • View at Publisher
• 
  72

  Gallicano, K., Foster, B., Choudhri, S.
  

  Effect of short-term administration of garlic supplements on single-dose ritonavir pharmacokinetics in healthy volunteers
  (2003) British Journal of Clinical Pharmacology, 55 (2), pp. 199-202. Cited 88 times.
  doi: 10.1046/j.1365-2125.2003.01736.x
  

  • View at Publisher
• 
  73

  Kasibhatta, R., Naidu, M.U.R.
  

  Influence of piperine on the pharmacokinetics of nevirapine under fasting conditions: A randomised, crossover, placebo-controlled study
  (2007) Drugs in R and D, 8 (6), pp. 383-391. Cited 23 times.
  

  • View at Publisher
• 
  74

  Bhardwaj, R.K., Glaeser, H., Becquemont, L., Klotz, U., Gupta, S.K., Fromm, M.F.
  

  Piperine, a major constituent of black pepper, inhibits human P-glycoprotein and CYP3A4
  (2002) Journal of Pharmacology and Experimental Therapeutics, 302 (2), pp. 645-650. Cited 227 times.
  doi: 10.1124/jpet.102.034728
  

  • View at Publisher
• 
  75

  Asase, A., Akwetey, G.A., Achel, D.G.
  

  Ethnopharmacological use of herbal remedies for the treatment of malaria in the Dangme West District of Ghana
  (2010) Journal of Ethnopharmacology, 129 (3), pp. 367-376. Cited 49 times.
  doi: 10.1016/j.jep.2010.04.001
  

  • View at Publisher
• 
  76

  Wells, T.N.C.
  

  Natural products as starting points for future anti-malarial therapies: Going back to our roots?
  (2011) Malaria Journal, 10 (SUPPL. 1), art. no. S3. Cited 44 times.
  doi: 10.1186/1475-2875-10-S1-S3
  

  • View at Publisher
• 
  77

  Oga, E.F., Sekine, S., Horie, T.
  

  Ex vivo and in vivo investigations of the effects of extracts of Vernonia amygdalina, Carica papaya and Tapinanthus sessilifolius on digoxin transport and pharmacokinetics: Assessing the significance on rat intestinal P-glycoprotein efflux
  (2013) Drug Metabolism and Pharmacokinetics, 28 (4), pp. 314-320. Cited 3 times.
  https://www.jstage.jst.go.jp/article/dmpk/28/4/28_DMPK-12-RG-117/_pdf
  doi: 10.2133/dmpk.DMPK-12-RG-117
  

  • View at Publisher
• 
  78

  Onaku, L.O., Attama, A.A., Okore, V.C., Tijani, A.Y., Ngene, A.A., Esimone, C.O.
  

  Antagonistic antimalarial properties of pawpaw leaf aqueous extract in combination with artesunic acid in plasmodium berghei-infected mice
  (2011) Journal of Vector Borne Diseases, 48 (2), pp. 96-100. Cited 6 times.
  http://www.mrcindia.org/journal/issues/482096.pdf
  
• 
  79

  Mohd Ridzuan, M.A., Sow, A., Noor Rain, A., Mohd Ilham, A., Zakiah, I.
  

  Eurycoma longifolia extract-artemisinin combination: parasitemia suppression of Plasmodium yoelii-infected mice.
  (2007) Tropical biomedicine, 24 (1), pp. 111-118. Cited 9 times.
  
• 
  80

  Mohd Ridzuan, M.A., Ruenruetai, U., Noor Rain, A., Khozirah, S., Zakiah, I.
  

  Antimalarial properties of Goniothalamin in combination with chloroquine against Plasmodium yoelii and Plasmodium berghei growth in mice.
  (2006) Tropical biomedicine, 23 (2), pp. 140-146. Cited 7 times.
  

View all 148 references

  Oga, E.F.; School of Pharmacy and Biomedical Sciences, University of Central Lancashire, United Kingdom; email:eoga@uclan.ac.uk
© Copyright 2016 Elsevier B.V., All rights reserved.